1
|
Xu N, Ijaz M, Shu Y, Wang P, Ma L, Wang P, Ding H, Shahbaz M, Shi H. The in vivo study on antioxidant activity of wendan decoction in treating hyperlipidemia: a pharmacokinetic-pharmacodynamic (PK-PD) model. Front Pharmacol 2024; 15:1260603. [PMID: 38323083 PMCID: PMC10844532 DOI: 10.3389/fphar.2024.1260603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Accepted: 01/08/2024] [Indexed: 02/08/2024] Open
Abstract
Background: Wendan Decoction (WDD) is a six-herb Chinese medicine recipe that was first mentioned in about 652 AD. It is frequently used to treat hyperlipidemic patients' clinical complaints. According to reports, oxidative stress has a significant role in hyperlipidemia. Purpose: There has not yet been a thorough pharmacokinetic-pharmacodynamic (PK-PD) examination of the clinical efficacy of WDD in the context of hyperlipemia-related oxidative stress. Therefore, the goal of this research is to explore the antioxidant essence of WDD by developing a PK-PD model, ordering to assure its implication in treating hyperlipidemia in medical practice. Methods: The model rats of foodborne hyperlipidemia were established by feeding with high-fat feed, and the lipid-lowering effect of WDD was explored. The plasma drug concentration of rats at different doses were measured by UPL-MS/MS technology, and PK parameters were calculated using Phoenix WinNonlin 8.1 software. The level of lipid peroxide (LPO) in plasma at different time points was measured by enzyme labeling instrument. Finally, the PK-PD model was established by using Phoenix WinNonlin 8.1 software, to explore the lipid-lowering effect of WDD and the relation between the dynamic changes of chemical components and antioxidant effect. Results: The findings suggested that, WDD can reduce the levels of triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) in plasma, and high-density lipoprotein cholesterol (HDL-C) was related to the dosage. Between the peak drug levels and the WDD's maximal therapeutic response, there existed a hysteresis. WDD's effect-concentration curves displayed a counterclockwise delaying loop. Alternatively, among the ten components of WDD, hesperetin, quercetin, naringenin and tangeretin might exert more significant effects in regulating the LPO levels in hyperlipidemic rats. Conclusion: This study can be helpful for other investigators to study the lipid-lowering effect of WDD.
Collapse
Affiliation(s)
- Nan Xu
- Laboratory of Chinese Medicine Preparation, Shandong Research Academy of Traditional Chinese Medicine, Jinan, China
- The Faculty of Medicine, Qilu Institute of Technology, Jinan, China
| | - Muhammad Ijaz
- The Faculty of Medicine, Qilu Institute of Technology, Jinan, China
- Department of Pharmacology, School of Pharmaceutical Science, Shandong University, Jinan, China
| | - Yishuo Shu
- Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Development, Jinan, China
| | - Peng Wang
- Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Development, Jinan, China
| | - Lei Ma
- Laboratory of Chinese Medicine Preparation, Shandong Research Academy of Traditional Chinese Medicine, Jinan, China
| | - Ping Wang
- Laboratory of Chinese Medicine Preparation, Shandong Research Academy of Traditional Chinese Medicine, Jinan, China
| | - Hailing Ding
- The Faculty of Medicine, Qilu Institute of Technology, Jinan, China
| | - Muhammad Shahbaz
- Laboratory of Chinese Medicine Preparation, Shandong Research Academy of Traditional Chinese Medicine, Jinan, China
- Research Center for Sectional and Imaging Anatomy, School of Basic Medical Science, Digital Human Institute, Shandong University, Jinan, Shandong, China
| | - Haiyan Shi
- The Faculty of Medicine, Qilu Institute of Technology, Jinan, China
- Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Department of Clinical Pharmacy, The First Affiliated Hospital of Shandong First Medical University, Shandong Provincial Qianfoshan Hospital, Shandong Engineering and Technology Research Center for Pediatric Drug Development, Jinan, China
| |
Collapse
|
2
|
Qi B, Guo M, Shi X, Li M, Wu Y, Wang Y, Lv Q, Fan X, Li C, Xu Y. A Network Pharmacology Approach and Validation Experiments to Investigate the Mechanism of Wen-Dan Decoction in the Treatment of SINFH. Comb Chem High Throughput Screen 2024; 27:1576-1591. [PMID: 38783679 DOI: 10.2174/0113862073266310231026070703] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2023] [Revised: 08/24/2023] [Accepted: 09/18/2023] [Indexed: 05/25/2024]
Abstract
INTRODUCTION Steroid-induced necrosis of the femoral head (SINFH) is a femoral head necrotic disease caused by prolonged use of hormones. Wen-Dan decoction is used in Chinese clinical practice for the treatment of steroid-induced necrosis of the femoral head (SINFH). However, the mechanism and active compounds of Wen-Dan decoction used to treat SINFH are not well understood. OBJECTIVES We studied the mechanism of action of Wen-Dan decoction in treating steroidinduced necrosis of the femoral head (SINFH) via network pharmacology and in vivo experiments. METHODS The active compounds of Wen-Dan decoction and SINFH-related target genes were identified through public databases. Then, network pharmacological analysis was conducted to explore the potential key active compounds, core targets and biological processes of Wen-Dan decoction in SINFH. The potential mechanisms of Wen-Dan decoction in SINFH obtained by network pharmacology were validated through in vivo experiments. RESULTS We identified 608 DEGs (differentially expressed genes) (230 upregulated, 378 downregulated) in SINFH. GO analysis revealed that the SINFH-related genes were mainly involved in neutrophil activation and the immune response. KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis showed that the SINFH-related genes were mainly associated with cytokine receptor interactions, lipids, atherosclerosis, and tuberculosis. We identified 147 active ingredients of Wen-Dan decoction; the core ingredient was quercetin, and licorice was an active ingredient. Moreover, 277 target genes in the treatment of SINFH with Wen-Dan decoction were identified, and NCF1, PTGS2, and RUNX2 were selected as core target genes. QRT-PCR of peripheral blood from SINFH patients showed higher levels of PGTS2 and NCF1 and showed lower levels of RUNX2 compared to controls. QRT-PCR analysis of peripheral blood and femoral bone tissue from a mouse model of SINFH showed higher levels of PGTS2 and NCF1 and lower levels of RUNX2 in the experimental animals than the controls, which was consistent with the bioinformatics results. HE, immunohistochemistry, and TUNEL staining confirmed a significant reduction in hormone-induced femoral head necrosis in the quercetintreated mice. HE, immunohistochemistry, and TUNEL staining confirmed significant improvement in hormone-induced femoral head necrosis in the quercetin-treated mice. CONCLUSION We provide new insights into the genes and related pathways involved in SINFH and report that PTGS2, RUNX2, and NCF1 are potential drug targets. Quercetin improved SINFH by promoting osteogenesis and inhibiting apoptosis.
Collapse
Affiliation(s)
- Baochuang Qi
- Graduate School, Kunming Medical University, Kunming, 650500, Yunnan, China
- Department of Orthopedics, 920th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Kunming, 650032, Yunnan, China
| | - Minzheng Guo
- Graduate School, Kunming Medical University, Kunming, 650500, Yunnan, China
- Department of Orthopedics, 920th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Kunming, 650032, Yunnan, China
| | - Xiangwen Shi
- Graduate School, Kunming Medical University, Kunming, 650500, Yunnan, China
| | - Mingjun Li
- Graduate School, Kunming Medical University, Kunming, 650500, Yunnan, China
| | - Yipeng Wu
- Department of Orthopedics, 920th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Kunming, 650032, Yunnan, China
| | - Yi Wang
- Department of Orthopedics, 920th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Kunming, 650032, Yunnan, China
| | - Qian Lv
- Department of Orthopedics, 920th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Kunming, 650032, Yunnan, China
| | - Xinyu Fan
- Department of Orthopedics, 920th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Kunming, 650032, Yunnan, China
| | - Chuan Li
- Department of Orthopedics, 920th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Kunming, 650032, Yunnan, China
| | - Yongqing Xu
- Department of Orthopedics, 920th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Kunming, 650032, Yunnan, China
| |
Collapse
|